EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure

Nicholas Rebold iD, Abdalhamid M Lagnf, Sara Alosaimy, Dana J Holger, Paige Witucki, Andrew Mannino, Michelle Dierker, Kristen Lucas, Ashlan J Kunz Coyne iD, Amer El Ghali, Kaylee E Caniff, Michael P Veve iD und 1 weitere

Microbiology Spectrum · 14.02.2023 · 11 (1)

DOI: 10.1128/spectrum.02647-22 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Microbiology Spectrum, erschienen am 14.02.2023. Verfasst von Nicholas Rebold und 12 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA. Hauptthemen laut MEDLINE: Carbapenems, Enterobacteriaceae Infections. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This work compares carbapenem-resistant Enterobacterales (CRE) infections using patient, clinical, and treatment variables to understand which characteristics are associated with the highest risk of clinical failure. Knowing which risk factors are associated with CRE infection failure can provide clinicians better prognostic and targeted interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarbapenemsEnterobacteriaceae InfectionsHumansAdolescentRetrospective StudiesAnti-Bacterial Agentsbeta-Lactamase InhibitorsTreatment FailureRisk FactorsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

CREEnterobacteralesEnterobacteriaceaeKlebsiellabeta-lactamscarbapenem resistancecarbapenemsceftazidime-avibactamclinical failureclinical therapeuticsdialysismeropenem-vaborbactamrisk factors

Substanzen

CarbapenemsAnti-Bacterial Agentsbeta-Lactamase Inhibitors

Autor:innen und Institutionen

  • College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.
  • Anti-Infective Research Laboratory, Department of Pharmacy Practice, College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.
  • Department of Pharmacy, Henry Ford Hospital, Henry Ford Health System, Detroit, Michigan, USA.
  • Detroit Receiving Hospital, Detroit Medical Center, Detroit, Michigan, USA.
  • School of Medicine, Wayne State University, Detroit, Michigan, USA.

ORCID-Profile: Nicholas Rebold, Ashlan J Kunz Coyne, Michael P Veve, Michael J Rybak

Förderung

  • NIAID NIH HHS

Zitieren

APA

Rebold, N., Lagnf, A. M., Alosaimy, S., Holger, D. J., Witucki, P., Mannino, A., Dierker, M., Lucas, K., Kunz Coyne, A. J., El Ghali, A., Caniff, K. E., Veve, M. P., & Rybak, M. J. (2023). Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology Spectrum, 11(1). https://doi.org/10.1128/spectrum.02647-22

Vancouver

Rebold N, Lagnf AM, Alosaimy S, Holger DJ, Witucki P, Mannino A, et al. Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology Spectrum. 2023;11(1). doi:10.1128/spectrum.02647-22

BibTeX
@article{Rebold2023,
  author = {Rebold, Nicholas and Lagnf, Abdalhamid M and Alosaimy, Sara and Holger, Dana J and Witucki, Paige and Mannino, Andrew and Dierker, Michelle and Lucas, Kristen and Kunz Coyne, Ashlan J and El Ghali, Amer and Caniff, Kaylee E and Veve, Michael P and Rybak, Michael J},
  title = {Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure},
  journal = {Microbiology Spectrum},
  year = {2023},
  volume = {11},
  number = {1},
  doi = {10.1128/spectrum.02647-22}
}
Kostenlos starten →